Skip to main content
. Author manuscript; available in PMC: 2021 Mar 5.
Published in final edited form as: J Urol. 2020 Sep 10;205(2):434–440. doi: 10.1097/JU.0000000000001355

Table 1.

Patient Characteristics and their Relationship with Other-Cause Mortality

Variable Levels %^ Unadjusted SHR (95% CI) P-value Adjusted SHR (95% CI) P-value
Demographics
Age at Diagnosis >80 yr 23.7 Reference Reference
65–70 yr 14.9 0.22 (0.16–0.29) <.001 0.24 (0.18–0.35) <.001
71–75 yr 33.6 0.31 (0.26–0.38) <.001 0.38 (0.30–0.46) <.001
76–80 yr 27.8 0.42 (0.35–0.51) <.001 0.47 (0.39–0.59) <.001
Married No 36.1 Reference Reference
Yes 63.9 0.67 (0.59–0.80) <.001 0.87 (0.74–1.03) 0.108
Race/Ethnicity Non-Hispanic White 83.7 Reference Reference
Black 9.5 1.36 (1.07–1.74) 0.013 0.94 (0.71–1.25) 0.665
Hispanic 2.7 0.51 (0.26–0.98) 0.043 0.43 (0.22–0.86) 0.017
Other 4.1 0.89 (0.60–1.35) 0.603 0.55 (0.36–0.86) 0.008
Rural/Urban Rural 13.1 Reference Reference
Urban 86.9 0.79 (0.64–0.98) 0.035 1.03 (0.81–1.32) 0.787
U.S. Region, 2010 Census South 28.0 Reference Reference
Northeast 17.8 0.74 (0.58–0.94) 0.013 0.80 (0.61–1.04) 0.098
Midwest 11.0 1.14 (0.58–1.56) 0.295 1.05 (0.81–1.35) 0.722
West 43.2 0.71 (0.59–0.86) <.001 0.82 (0.66–1.01) 0.059
Poverty Indicator 0%-<5% 25.2 Reference Reference
5% to <10% 25.6 1.18 (0.93–1.49) 0.166 1.04 (0.81–1.32) 0.765
10% to <20% 29.1 1.45 (1.16–1.79) 0.001 1.17 (0.92–1.50) 0.198
20% to 100% 19.0 1.67 (1.32–2.12) <.001 1.14 (0.86–1.50) 0.370
Unknown/Missing 1.1 2.17 (1.10–4.26) 0.025 1.82 (0.90–3.68) 0.095
Education 4-year or more college graduate 29.8 Reference Reference
High school graduate or GED 26.3 1.27 (1.01–1.59) 0.041 1.03 (0.81–1.29) 0.840
Some college or 2-year degree 21.7 1.16 (0.91–1.48) 0.216 1.05 (0.82–1.34) 0.719
8th grade or less, some high school 19.5 1.98 (1.59–2.46) <.001 1.24 (0.97–1.59) 0.094
Unknown/Missing 2.8 2.05 (1.32–3.18) 0.001 1.26 (0.80–2.00) 0.325
Cancer Information
AJCC Stage Stage I/ II 82.8 Reference Reference
Stage III 4.9 0.68 (0.44–1.07) 0.094 0.92 (0.58–1.45) 0.714
Stage IV 7.2 2.21 (1.60–3.04) <.001 1.50 (1.05–2.15) 0.027
Unknown/Missing 5.1 2.35 (1.73–3.18) <.001 1.50 (1.06–2.14) 0.024
PSA <10.0 ng/ml 54.2 Reference Reference
10.0–20.0 ng/ml 14.5 1.95 (1.57–2.41) <.001 1.50 (1.20–1.88) <.001
>20.0 ng/ml 12.4 2.39 (1.89–3.03) <.001 1.55 (1.19–2.02) 0.001
Unknown/Missing 18.9 1.99 (1.63–2.44) <.001 1.31 (1.05–1.63) 0.018
Gleason Score 0–6 35.3 Reference Reference
7 36.2 0.86 (0.71–1.04) 0.115 0.80 (0.66–0.97) 0.026
8–10 21.4 1.45 (1.17–1.76) <.001 1.09 (0.87–1.36) 0.468
Unknown/Missing 7.1 2.38 (1.77–3.21) <.001 1.34 (0.94–1.90) 0.106
Claims-based Health Measures
NCI Comorbidity Index Score 0 61.9 Reference Reference
1 22.4 1.59 (1.32–1.91) <.001 1.37 (1.13–1.66) 0.001
2 9.5 1.88 (1.47–2.41) <.001 1.46 (1.13–1.90) 0.005
3+ 6.2 2.38 (1.98–3.16) <.001 1.51 (1.12–2.04) 0.007
Frailty Indicator Count 0 68.6 Reference Reference
1 27.5 2.01 (1.70–2.37) <.001 1.50 (1.26–1.79) <.001
2+ 4.0 3.89 (2.91–5.22) <.001 2.74 (2.01–3.75) <.001
Patient-reported Health Measures
Smoking No 90.6 Reference Reference
Yes 9.4 1.46 (1.15–1.87) 0.002 1.40 (1.08–1.81) 0.010
Mental Health Excellent 34.3 Reference Reference
Very Good 33.0 1.53 (1.27–1.89) <.001 1.16 (0.93–1.46) 0.211
Good 24.1 2.05 (1.66–2.54) <.001 1.33 (1.04–1.70) 0.023
Fair/Poor 8.7 2.42 (1.84–3.18) <.001 1.13 (0.81–1.57) 0.482
Overall Health Excellent 10.9 Reference Reference
Very Good 32.2 1.44 (1.00–2.09) 0.050 1.25 (0.85–1.84) 0.250
Good 36.4 2.11 (1.48–3.00) <.001 1.44 (0.98–2.12) 0.066
Fair/Poor 20.6 3.77 (2.63–5.39) <.001 2.24 (1.48–3.40) <.001
Functional Deficit No 75.6 Reference Reference
Yes 24.4 1.91 (1.62–2.25) <.001 1.16 (0.96–1.41) 0.112
^

Made not sum to 100% due to rounding.